ProNAi Therapeutics CEO Stephen Dilly receives $8.2M in 2020
ProNAi Therapeutics reports 2020 executive compensation
By ExecPay News
Published: April 23, 2021
ProNAi Therapeutics reported fiscal year 2020 executive compensation information on April 23, 2021.
In 2020, four executives at ProNAi Therapeutics received on average a compensation package of $4.4M, a 245% increase compared to previous year.
Average pay of disclosed executives at ProNAi Therapeutics
Stephen G. Dilly, Chief Executive Officer, received $8.2M in total. 94% of Dilly's compensation, or $7.6M, was in option awards. Dilly also received $175K in non-equity incentive plan, $350K in salary, as well as $4K in other compensation.
Nick Glover, Chief Executive Officer, received a compensation package of $4.4M, which increased by 132% compared to previous year. 79% of the compensation package, or $3.5M, was in option awards.
Barbara Klencke, Chief Development Officer, earned $2.8M in 2020, a 186% increase compared to previous year.
Mark Kowalski, Chief Medical Officer, received $2M in 2020, which increases by 125% compared to 2019.
Related executives
You may also like
Source: SEC filing on April 23, 2021.